Fundraising FoxClal Biotechnology Industries
Venture capitalTel Aviv · Seed–Late Stage · 8 people tracked
Find your way into Clal Biotechnology Industries
Sign up to see every warm intro you have to Clal Biotechnology Industries
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Clal Biotechnology Industries team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
CBI concentrates on the life sciences sector, backing companies that develop proprietary solutions addressing unmet medical needs with significant market potential. It builds and oversees a global portfolio of innovative healthcare ventures, aiming to advance treatments worldwide. As a publicly listed investment firm, CBI identifies and nurtures groundbreaking science-driven businesses from an early stage through their development.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 11 of 11 portfolio companiesBiotech ×9Healthtech ×8Medical Devices ×6Digital Health ×4AI & Machine Learning ×2Hardware ×2
HQs:United States×4Israel×2
Investments · 11 tracked
founders shown can be your intro pathBy year:2018 · 12012 · 12 dated
MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds.
BiotechHealthtechMedical DevicesYavne
Boaz Gur-Lavie(Chief Financial Officer)inSharon Malka(Director)inEty Klinger(Executive Officer, Director)inTzvi Palash(Executive Officer)Assaf Segal(Director)Sharon Kochan(Director)
PartnerAvi Fischer· solo GP
Co-investorsDeep InsightGandyr InvestmentsIsrael Biotech FundNew Era Capital PartnersPoint72 Ventures
BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
BiotechDigital HealthHealthtechMedical DevicesJerusalem, IL
Amnon Peled(CEO/CSO)Simone Cabilly(Chief Scientist)
PartnerAvi Fischer· solo GP
Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsQiming Venture Partners USASlater Technology FundAccess IndustriesAtlas VentureCowen Healthcare InvestmentsNovartis Institute for Biomedical Research+1 more
Colospan develops the CG-100, an internal bypass medical device for colorectal surgery that provides an alternative to stoma pouches.
BiotechHardwareHealthtechMedical DevicesKfar Saba, IL
Boaz Assaf(CEO)in
PartnerAvi Fischer· solo GP
Co-investorsTriventures
Elicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.
BiotechHealthtech
PartnerAvi Fischer· solo GP
Co-investorsEFung Capital
FDNA develops AI-powered diagnosis and care management tools that help parents, clinicians, and researchers identify developmental delays and rare genetic disorders early.
AI & Machine LearningDigital HealthHealthtechMedical DevicesBoston, US
Moti ShnibergProfessor Lior WolfErik Feingold(Co-Founder and CEO)in
PartnerAvi Fischer· solo GP
BiotechCambridge, US
Richard Gaynor, M.D.(Executive Officer)inRobert Ang, M.D.(Executive Officer)Yasir Al-Wakeel(Executive Officer)inEric Lander(Director)Hugh Dowd(Executive Officer, Director)
BoardCary Pfeffer, M.D.(Director)
Co-investorsNextech InvestSofinnova VenturesThird Rock VenturesWellington Management
Pi-Cardia develops non-implant-based, catheter-delivered devices for treating structural heart disease, including its ShortCut product for leaflet modification.
HardwareHealthtechMedical Devices
Erez Golan(Founder)in
PartnerAvi Fischer· solo GP
Co-investorsAccelmed PartnersIndaco Venture PartnersKreos CapitalSofinnova PartnersInnogest Capital
Sight develops immune signatures by analyzing live immune cells using AI to generate clinical insights.
AI & Machine LearningBiotechDigital Health
Ben Leshem(Chief Technology Officer)Nitsan Maayan-Rabinowich(Chief Executive Officer)Asi Cohen-Dotan(Chief Product & Clinical Officer)
PartnerAvi Fischer· solo GP
Co-investorsEmery CapitalGEOC
Constellation Pharmaceuticals was a Cambridge, MA clinical-stage biopharmaceutical company developing epigenetics-based cancer therapies, including BET and EZH2 inhibitors.
BiotechHealthtech
PartnerAvi Fischer· solo GP
Co-investorsExSight VenturesLongitude CapitalTachyon VenturesThe Column Group
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 3
1 IPOs · 2 acquisitionsMediwoundNASDAQ: MDWDCadenttxacq. by NovartisThumbnail for Constellation Pharmaceuticalsacq. by MorphoSys
Frequently asked questions
- How many investments has Clal Biotechnology Industries made?
- Clal Biotechnology Industries has 11 tracked investments, 3 of which have exited.
- What stage does Clal Biotechnology Industries invest at?
- Clal Biotechnology Industries invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Clal Biotechnology Industries focus on?
- Clal Biotechnology Industries focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Clal Biotechnology Industries located?
- Clal Biotechnology Industries is headquartered in Tel Aviv, IL.
- Who does Clal Biotechnology Industries co-invest with?
- Clal Biotechnology Industries most often shares deals with Indaco Venture Partners, Kreos Capital, Longitude Capital, among 16 tracked co-investors.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.